Mirae Asset Global Etfs Holdings Ltd. Madrigal Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 12,489 shares of MDGL stock, worth $5.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,489
Previous 13,858
9.88%
Holding current value
$5.53 Million
Previous $4.59 Million
17.67%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding MDGL
# of Institutions
356Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$971 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$926 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$883 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$875 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$832 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.58B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...